nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—TOP2A—Epirubicin—liver cancer	0.219	0.323	CbGbCtD
Ofloxacin—ABCC1—Epirubicin—liver cancer	0.121	0.179	CbGbCtD
Ofloxacin—TOP2A—Doxorubicin—liver cancer	0.116	0.172	CbGbCtD
Ofloxacin—ABCC2—Sorafenib—liver cancer	0.0786	0.116	CbGbCtD
Ofloxacin—ABCC1—Doxorubicin—liver cancer	0.0645	0.0952	CbGbCtD
Ofloxacin—ABCC2—Doxorubicin—liver cancer	0.0477	0.0705	CbGbCtD
Ofloxacin—ABCC2—bile canaliculus—liver cancer	0.0457	0.618	CbGeAlD
Ofloxacin—CYP1A2—Sorafenib—liver cancer	0.0293	0.0433	CbGbCtD
Ofloxacin—ABCC2—bile duct—liver cancer	0.0143	0.193	CbGeAlD
Ofloxacin—ABCC2—bile—liver cancer	0.011	0.148	CbGeAlD
Ofloxacin—ABCC2—liver—liver cancer	0.000893	0.0121	CbGeAlD
Ofloxacin—ABCC1—liver—liver cancer	0.000786	0.0106	CbGeAlD
Ofloxacin—SLC22A5—liver—liver cancer	0.000692	0.00935	CbGeAlD
Ofloxacin—TOP2A—Idarubicin—Epirubicin—liver cancer	0.000686	0.173	CbGdCrCtD
Ofloxacin—TOP2A—Doxorubicin—Epirubicin—liver cancer	0.000686	0.173	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Epirubicin—liver cancer	0.000686	0.173	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Doxorubicin—liver cancer	0.000634	0.16	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Doxorubicin—liver cancer	0.000634	0.16	CbGdCrCtD
Ofloxacin—TOP2A—Epirubicin—Doxorubicin—liver cancer	0.000634	0.16	CbGdCrCtD
Ofloxacin—CYP1A2—liver—liver cancer	0.000627	0.00847	CbGeAlD
Ofloxacin—Gatifloxacin—ALB—liver cancer	0.000383	0.599	CrCbGaD
Ofloxacin—Norfloxacin—CYP1A1—liver cancer	0.000256	0.401	CrCbGaD
Ofloxacin—Dysphagia—Epirubicin—liver cancer	0.000181	0.000934	CcSEcCtD
Ofloxacin—Asthma—Epirubicin—liver cancer	0.000181	0.000934	CcSEcCtD
Ofloxacin—Dehydration—Doxorubicin—liver cancer	0.00018	0.00093	CcSEcCtD
Ofloxacin—Eosinophilia—Epirubicin—liver cancer	0.000179	0.000925	CcSEcCtD
Ofloxacin—Dry skin—Doxorubicin—liver cancer	0.000177	0.000916	CcSEcCtD
Ofloxacin—Pancreatitis—Epirubicin—liver cancer	0.000177	0.000916	CcSEcCtD
Ofloxacin—Vomiting—Sorafenib—liver cancer	0.000177	0.000914	CcSEcCtD
Ofloxacin—Orthostatic hypotension—Doxorubicin—liver cancer	0.000177	0.000913	CcSEcCtD
Ofloxacin—Hypokalaemia—Doxorubicin—liver cancer	0.000176	0.00091	CcSEcCtD
Ofloxacin—Angina pectoris—Epirubicin—liver cancer	0.000176	0.00091	CcSEcCtD
Ofloxacin—Rash—Sorafenib—liver cancer	0.000175	0.000906	CcSEcCtD
Ofloxacin—Dermatitis—Sorafenib—liver cancer	0.000175	0.000905	CcSEcCtD
Ofloxacin—Breast disorder—Doxorubicin—liver cancer	0.000175	0.000903	CcSEcCtD
Ofloxacin—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000174	0.0009	CcSEcCtD
Ofloxacin—Headache—Sorafenib—liver cancer	0.000174	0.0009	CcSEcCtD
Ofloxacin—Bronchitis—Epirubicin—liver cancer	0.000174	0.000898	CcSEcCtD
Ofloxacin—Nasopharyngitis—Doxorubicin—liver cancer	0.000173	0.000894	CcSEcCtD
Ofloxacin—Pancytopenia—Epirubicin—liver cancer	0.000172	0.000887	CcSEcCtD
Ofloxacin—Gastritis—Doxorubicin—liver cancer	0.000171	0.000885	CcSEcCtD
Ofloxacin—Dysuria—Epirubicin—liver cancer	0.000169	0.000873	CcSEcCtD
Ofloxacin—Neutropenia—Epirubicin—liver cancer	0.000169	0.000873	CcSEcCtD
Ofloxacin—Abdominal distension—Doxorubicin—liver cancer	0.000168	0.00087	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Epirubicin—liver cancer	0.000168	0.000868	CcSEcCtD
Ofloxacin—Dysphagia—Doxorubicin—liver cancer	0.000167	0.000864	CcSEcCtD
Ofloxacin—Asthma—Doxorubicin—liver cancer	0.000167	0.000864	CcSEcCtD
Ofloxacin—Pollakiuria—Epirubicin—liver cancer	0.000167	0.000863	CcSEcCtD
Ofloxacin—Eosinophilia—Doxorubicin—liver cancer	0.000166	0.000856	CcSEcCtD
Ofloxacin—Nausea—Sorafenib—liver cancer	0.000165	0.000854	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Epirubicin—liver cancer	0.000165	0.000852	CcSEcCtD
Ofloxacin—Pancreatitis—Doxorubicin—liver cancer	0.000164	0.000847	CcSEcCtD
Ofloxacin—Weight decreased—Epirubicin—liver cancer	0.000164	0.000845	CcSEcCtD
Ofloxacin—Hyperglycaemia—Epirubicin—liver cancer	0.000163	0.000842	CcSEcCtD
Ofloxacin—Angina pectoris—Doxorubicin—liver cancer	0.000163	0.000842	CcSEcCtD
Ofloxacin—Pneumonia—Epirubicin—liver cancer	0.000162	0.000837	CcSEcCtD
Ofloxacin—Infestation NOS—Epirubicin—liver cancer	0.000161	0.000833	CcSEcCtD
Ofloxacin—Infestation—Epirubicin—liver cancer	0.000161	0.000833	CcSEcCtD
Ofloxacin—Drowsiness—Epirubicin—liver cancer	0.000161	0.000833	CcSEcCtD
Ofloxacin—Bronchitis—Doxorubicin—liver cancer	0.000161	0.000831	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00016	0.000826	CcSEcCtD
Ofloxacin—Pancytopenia—Doxorubicin—liver cancer	0.000159	0.000821	CcSEcCtD
Ofloxacin—Renal failure—Epirubicin—liver cancer	0.000158	0.000818	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Epirubicin—liver cancer	0.000158	0.000816	CcSEcCtD
Ofloxacin—Jaundice—Epirubicin—liver cancer	0.000157	0.000812	CcSEcCtD
Ofloxacin—Stomatitis—Epirubicin—liver cancer	0.000157	0.000812	CcSEcCtD
Ofloxacin—Conjunctivitis—Epirubicin—liver cancer	0.000157	0.000809	CcSEcCtD
Ofloxacin—Dysuria—Doxorubicin—liver cancer	0.000156	0.000808	CcSEcCtD
Ofloxacin—Neutropenia—Doxorubicin—liver cancer	0.000156	0.000808	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000155	0.000803	CcSEcCtD
Ofloxacin—Pollakiuria—Doxorubicin—liver cancer	0.000155	0.000798	CcSEcCtD
Ofloxacin—Haematuria—Epirubicin—liver cancer	0.000154	0.000794	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Doxorubicin—liver cancer	0.000153	0.000789	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Epirubicin—liver cancer	0.000152	0.000787	CcSEcCtD
Ofloxacin—Epistaxis—Epirubicin—liver cancer	0.000152	0.000785	CcSEcCtD
Ofloxacin—Weight decreased—Doxorubicin—liver cancer	0.000151	0.000782	CcSEcCtD
Ofloxacin—Sinusitis—Epirubicin—liver cancer	0.000151	0.000781	CcSEcCtD
Ofloxacin—Hyperglycaemia—Doxorubicin—liver cancer	0.000151	0.000779	CcSEcCtD
Ofloxacin—Agranulocytosis—Epirubicin—liver cancer	0.00015	0.000777	CcSEcCtD
Ofloxacin—Pneumonia—Doxorubicin—liver cancer	0.00015	0.000775	CcSEcCtD
Ofloxacin—Infestation NOS—Doxorubicin—liver cancer	0.000149	0.00077	CcSEcCtD
Ofloxacin—Drowsiness—Doxorubicin—liver cancer	0.000149	0.00077	CcSEcCtD
Ofloxacin—Infestation—Doxorubicin—liver cancer	0.000149	0.00077	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000148	0.000764	CcSEcCtD
Ofloxacin—Bradycardia—Epirubicin—liver cancer	0.000147	0.000761	CcSEcCtD
Ofloxacin—Renal failure—Doxorubicin—liver cancer	0.000147	0.000757	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Doxorubicin—liver cancer	0.000146	0.000755	CcSEcCtD
Ofloxacin—Haemoglobin—Epirubicin—liver cancer	0.000145	0.000751	CcSEcCtD
Ofloxacin—Stomatitis—Doxorubicin—liver cancer	0.000145	0.000751	CcSEcCtD
Ofloxacin—Jaundice—Doxorubicin—liver cancer	0.000145	0.000751	CcSEcCtD
Ofloxacin—Rhinitis—Epirubicin—liver cancer	0.000145	0.000749	CcSEcCtD
Ofloxacin—Conjunctivitis—Doxorubicin—liver cancer	0.000145	0.000749	CcSEcCtD
Ofloxacin—Haemorrhage—Epirubicin—liver cancer	0.000145	0.000747	CcSEcCtD
Ofloxacin—Hepatitis—Epirubicin—liver cancer	0.000145	0.000747	CcSEcCtD
Ofloxacin—Hypoaesthesia—Epirubicin—liver cancer	0.000144	0.000744	CcSEcCtD
Ofloxacin—Pharyngitis—Epirubicin—liver cancer	0.000144	0.000742	CcSEcCtD
Ofloxacin—Urinary tract disorder—Epirubicin—liver cancer	0.000143	0.000738	CcSEcCtD
Ofloxacin—Oedema peripheral—Epirubicin—liver cancer	0.000143	0.000736	CcSEcCtD
Ofloxacin—Haematuria—Doxorubicin—liver cancer	0.000142	0.000735	CcSEcCtD
Ofloxacin—Connective tissue disorder—Epirubicin—liver cancer	0.000142	0.000735	CcSEcCtD
Ofloxacin—Urethral disorder—Epirubicin—liver cancer	0.000142	0.000733	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Doxorubicin—liver cancer	0.000141	0.000729	CcSEcCtD
Ofloxacin—Epistaxis—Doxorubicin—liver cancer	0.000141	0.000727	CcSEcCtD
Ofloxacin—Sinusitis—Doxorubicin—liver cancer	0.00014	0.000723	CcSEcCtD
Ofloxacin—Visual impairment—Epirubicin—liver cancer	0.000139	0.00072	CcSEcCtD
Ofloxacin—Agranulocytosis—Doxorubicin—liver cancer	0.000139	0.000719	CcSEcCtD
Ofloxacin—Erythema multiforme—Epirubicin—liver cancer	0.000137	0.000707	CcSEcCtD
Ofloxacin—Bradycardia—Doxorubicin—liver cancer	0.000136	0.000704	CcSEcCtD
Ofloxacin—Eye disorder—Epirubicin—liver cancer	0.000135	0.000699	CcSEcCtD
Ofloxacin—Tinnitus—Epirubicin—liver cancer	0.000135	0.000697	CcSEcCtD
Ofloxacin—Haemoglobin—Doxorubicin—liver cancer	0.000135	0.000695	CcSEcCtD
Ofloxacin—Cardiac disorder—Epirubicin—liver cancer	0.000134	0.000694	CcSEcCtD
Ofloxacin—Flushing—Epirubicin—liver cancer	0.000134	0.000694	CcSEcCtD
Ofloxacin—Rhinitis—Doxorubicin—liver cancer	0.000134	0.000693	CcSEcCtD
Ofloxacin—Hepatitis—Doxorubicin—liver cancer	0.000134	0.000692	CcSEcCtD
Ofloxacin—Haemorrhage—Doxorubicin—liver cancer	0.000134	0.000692	CcSEcCtD
Ofloxacin—Hypoaesthesia—Doxorubicin—liver cancer	0.000133	0.000688	CcSEcCtD
Ofloxacin—Pharyngitis—Doxorubicin—liver cancer	0.000133	0.000686	CcSEcCtD
Ofloxacin—Urinary tract disorder—Doxorubicin—liver cancer	0.000132	0.000683	CcSEcCtD
Ofloxacin—Oedema peripheral—Doxorubicin—liver cancer	0.000132	0.000681	CcSEcCtD
Ofloxacin—Connective tissue disorder—Doxorubicin—liver cancer	0.000132	0.00068	CcSEcCtD
Ofloxacin—Angiopathy—Epirubicin—liver cancer	0.000131	0.000678	CcSEcCtD
Ofloxacin—Urethral disorder—Doxorubicin—liver cancer	0.000131	0.000678	CcSEcCtD
Ofloxacin—Immune system disorder—Epirubicin—liver cancer	0.000131	0.000675	CcSEcCtD
Ofloxacin—Mediastinal disorder—Epirubicin—liver cancer	0.00013	0.000674	CcSEcCtD
Ofloxacin—Chills—Epirubicin—liver cancer	0.00013	0.000671	CcSEcCtD
Ofloxacin—Arrhythmia—Epirubicin—liver cancer	0.000129	0.000668	CcSEcCtD
Ofloxacin—Visual impairment—Doxorubicin—liver cancer	0.000129	0.000667	CcSEcCtD
Ofloxacin—Alopecia—Epirubicin—liver cancer	0.000128	0.000661	CcSEcCtD
Ofloxacin—Mental disorder—Epirubicin—liver cancer	0.000127	0.000655	CcSEcCtD
Ofloxacin—Erythema multiforme—Doxorubicin—liver cancer	0.000127	0.000654	CcSEcCtD
Ofloxacin—Erythema—Epirubicin—liver cancer	0.000126	0.000651	CcSEcCtD
Ofloxacin—Malnutrition—Epirubicin—liver cancer	0.000126	0.000651	CcSEcCtD
Ofloxacin—Eye disorder—Doxorubicin—liver cancer	0.000125	0.000646	CcSEcCtD
Ofloxacin—Tinnitus—Doxorubicin—liver cancer	0.000125	0.000645	CcSEcCtD
Ofloxacin—Cardiac disorder—Doxorubicin—liver cancer	0.000124	0.000642	CcSEcCtD
Ofloxacin—Flushing—Doxorubicin—liver cancer	0.000124	0.000642	CcSEcCtD
Ofloxacin—Flatulence—Epirubicin—liver cancer	0.000124	0.000641	CcSEcCtD
Ofloxacin—Tension—Epirubicin—liver cancer	0.000124	0.000639	CcSEcCtD
Ofloxacin—Dysgeusia—Epirubicin—liver cancer	0.000123	0.000637	CcSEcCtD
Ofloxacin—Nervousness—Epirubicin—liver cancer	0.000122	0.000632	CcSEcCtD
Ofloxacin—Back pain—Epirubicin—liver cancer	0.000122	0.000629	CcSEcCtD
Ofloxacin—Angiopathy—Doxorubicin—liver cancer	0.000121	0.000627	CcSEcCtD
Ofloxacin—Muscle spasms—Epirubicin—liver cancer	0.000121	0.000626	CcSEcCtD
Ofloxacin—Immune system disorder—Doxorubicin—liver cancer	0.000121	0.000625	CcSEcCtD
Ofloxacin—Mediastinal disorder—Doxorubicin—liver cancer	0.000121	0.000623	CcSEcCtD
Ofloxacin—Chills—Doxorubicin—liver cancer	0.00012	0.000621	CcSEcCtD
Ofloxacin—Arrhythmia—Doxorubicin—liver cancer	0.00012	0.000618	CcSEcCtD
Ofloxacin—Vision blurred—Epirubicin—liver cancer	0.000119	0.000613	CcSEcCtD
Ofloxacin—Alopecia—Doxorubicin—liver cancer	0.000118	0.000611	CcSEcCtD
Ofloxacin—Mental disorder—Doxorubicin—liver cancer	0.000117	0.000606	CcSEcCtD
Ofloxacin—Ill-defined disorder—Epirubicin—liver cancer	0.000117	0.000604	CcSEcCtD
Ofloxacin—Erythema—Doxorubicin—liver cancer	0.000117	0.000602	CcSEcCtD
Ofloxacin—Malnutrition—Doxorubicin—liver cancer	0.000117	0.000602	CcSEcCtD
Ofloxacin—Anaemia—Epirubicin—liver cancer	0.000116	0.000601	CcSEcCtD
Ofloxacin—Agitation—Epirubicin—liver cancer	0.000116	0.000598	CcSEcCtD
Ofloxacin—Flatulence—Doxorubicin—liver cancer	0.000115	0.000593	CcSEcCtD
Ofloxacin—Tension—Doxorubicin—liver cancer	0.000114	0.000591	CcSEcCtD
Ofloxacin—Dysgeusia—Doxorubicin—liver cancer	0.000114	0.00059	CcSEcCtD
Ofloxacin—Malaise—Epirubicin—liver cancer	0.000114	0.000587	CcSEcCtD
Ofloxacin—Nervousness—Doxorubicin—liver cancer	0.000113	0.000585	CcSEcCtD
Ofloxacin—Vertigo—Epirubicin—liver cancer	0.000113	0.000585	CcSEcCtD
Ofloxacin—Syncope—Epirubicin—liver cancer	0.000113	0.000584	CcSEcCtD
Ofloxacin—Leukopenia—Epirubicin—liver cancer	0.000113	0.000582	CcSEcCtD
Ofloxacin—Back pain—Doxorubicin—liver cancer	0.000113	0.000582	CcSEcCtD
Ofloxacin—Muscle spasms—Doxorubicin—liver cancer	0.000112	0.000579	CcSEcCtD
Ofloxacin—Palpitations—Epirubicin—liver cancer	0.000111	0.000575	CcSEcCtD
Ofloxacin—Loss of consciousness—Epirubicin—liver cancer	0.000111	0.000572	CcSEcCtD
Ofloxacin—Cough—Epirubicin—liver cancer	0.00011	0.000568	CcSEcCtD
Ofloxacin—Vision blurred—Doxorubicin—liver cancer	0.00011	0.000567	CcSEcCtD
Ofloxacin—Hypertension—Epirubicin—liver cancer	0.000109	0.000562	CcSEcCtD
Ofloxacin—Ill-defined disorder—Doxorubicin—liver cancer	0.000108	0.000559	CcSEcCtD
Ofloxacin—Anaemia—Doxorubicin—liver cancer	0.000108	0.000556	CcSEcCtD
Ofloxacin—Myalgia—Epirubicin—liver cancer	0.000107	0.000554	CcSEcCtD
Ofloxacin—Chest pain—Epirubicin—liver cancer	0.000107	0.000554	CcSEcCtD
Ofloxacin—Arthralgia—Epirubicin—liver cancer	0.000107	0.000554	CcSEcCtD
Ofloxacin—Agitation—Doxorubicin—liver cancer	0.000107	0.000553	CcSEcCtD
Ofloxacin—Anxiety—Epirubicin—liver cancer	0.000107	0.000552	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000106	0.00055	CcSEcCtD
Ofloxacin—Discomfort—Epirubicin—liver cancer	0.000106	0.000547	CcSEcCtD
Ofloxacin—Malaise—Doxorubicin—liver cancer	0.000105	0.000543	CcSEcCtD
Ofloxacin—Dry mouth—Epirubicin—liver cancer	0.000105	0.000542	CcSEcCtD
Ofloxacin—Vertigo—Doxorubicin—liver cancer	0.000105	0.000541	CcSEcCtD
Ofloxacin—Syncope—Doxorubicin—liver cancer	0.000105	0.00054	CcSEcCtD
Ofloxacin—Leukopenia—Doxorubicin—liver cancer	0.000104	0.000539	CcSEcCtD
Ofloxacin—Confusional state—Epirubicin—liver cancer	0.000104	0.000535	CcSEcCtD
Ofloxacin—Palpitations—Doxorubicin—liver cancer	0.000103	0.000532	CcSEcCtD
Ofloxacin—Oedema—Epirubicin—liver cancer	0.000103	0.000531	CcSEcCtD
Ofloxacin—Anaphylactic shock—Epirubicin—liver cancer	0.000103	0.000531	CcSEcCtD
Ofloxacin—Loss of consciousness—Doxorubicin—liver cancer	0.000102	0.000529	CcSEcCtD
Ofloxacin—Infection—Epirubicin—liver cancer	0.000102	0.000528	CcSEcCtD
Ofloxacin—Cough—Doxorubicin—liver cancer	0.000102	0.000525	CcSEcCtD
Ofloxacin—Shock—Epirubicin—liver cancer	0.000101	0.000522	CcSEcCtD
Ofloxacin—Nervous system disorder—Epirubicin—liver cancer	0.000101	0.000521	CcSEcCtD
Ofloxacin—Thrombocytopenia—Epirubicin—liver cancer	0.000101	0.00052	CcSEcCtD
Ofloxacin—Hypertension—Doxorubicin—liver cancer	0.000101	0.00052	CcSEcCtD
Ofloxacin—Tachycardia—Epirubicin—liver cancer	0.0001	0.000518	CcSEcCtD
Ofloxacin—Skin disorder—Epirubicin—liver cancer	9.99e-05	0.000516	CcSEcCtD
Ofloxacin—Hyperhidrosis—Epirubicin—liver cancer	9.94e-05	0.000513	CcSEcCtD
Ofloxacin—Chest pain—Doxorubicin—liver cancer	9.92e-05	0.000513	CcSEcCtD
Ofloxacin—Myalgia—Doxorubicin—liver cancer	9.92e-05	0.000513	CcSEcCtD
Ofloxacin—Arthralgia—Doxorubicin—liver cancer	9.92e-05	0.000513	CcSEcCtD
Ofloxacin—Anxiety—Doxorubicin—liver cancer	9.89e-05	0.000511	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	9.85e-05	0.000509	CcSEcCtD
Ofloxacin—Discomfort—Doxorubicin—liver cancer	9.8e-05	0.000506	CcSEcCtD
Ofloxacin—Anorexia—Epirubicin—liver cancer	9.8e-05	0.000506	CcSEcCtD
Ofloxacin—Dry mouth—Doxorubicin—liver cancer	9.7e-05	0.000501	CcSEcCtD
Ofloxacin—Hypotension—Epirubicin—liver cancer	9.61e-05	0.000496	CcSEcCtD
Ofloxacin—Confusional state—Doxorubicin—liver cancer	9.59e-05	0.000495	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC40A1—liver cancer	9.51e-05	0.00186	CbGpPWpGaD
Ofloxacin—Oedema—Doxorubicin—liver cancer	9.51e-05	0.000491	CcSEcCtD
Ofloxacin—Anaphylactic shock—Doxorubicin—liver cancer	9.51e-05	0.000491	CcSEcCtD
Ofloxacin—Infection—Doxorubicin—liver cancer	9.45e-05	0.000488	CcSEcCtD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—CYP1A1—liver cancer	9.43e-05	0.00185	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	9.41e-05	0.00184	CbGpPWpGaD
Ofloxacin—Musculoskeletal discomfort—Epirubicin—liver cancer	9.37e-05	0.000484	CcSEcCtD
Ofloxacin—Shock—Doxorubicin—liver cancer	9.36e-05	0.000483	CcSEcCtD
Ofloxacin—Nervous system disorder—Doxorubicin—liver cancer	9.33e-05	0.000482	CcSEcCtD
Ofloxacin—Thrombocytopenia—Doxorubicin—liver cancer	9.31e-05	0.000481	CcSEcCtD
Ofloxacin—Insomnia—Epirubicin—liver cancer	9.3e-05	0.00048	CcSEcCtD
Ofloxacin—Tachycardia—Doxorubicin—liver cancer	9.28e-05	0.00048	CcSEcCtD
Ofloxacin—Skin disorder—Doxorubicin—liver cancer	9.24e-05	0.000477	CcSEcCtD
Ofloxacin—Paraesthesia—Epirubicin—liver cancer	9.23e-05	0.000477	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ANXA2—liver cancer	9.23e-05	0.00181	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ATP7B—liver cancer	9.23e-05	0.00181	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	9.2e-05	0.0018	CbGpPWpGaD
Ofloxacin—Hyperhidrosis—Doxorubicin—liver cancer	9.2e-05	0.000475	CcSEcCtD
Ofloxacin—Dyspnoea—Epirubicin—liver cancer	9.17e-05	0.000473	CcSEcCtD
Ofloxacin—Somnolence—Epirubicin—liver cancer	9.14e-05	0.000472	CcSEcCtD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—liver cancer	9.13e-05	0.00179	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ATP7B—liver cancer	9.12e-05	0.00178	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ANXA2—liver cancer	9.12e-05	0.00178	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	9.07e-05	0.00178	CbGpPWpGaD
Ofloxacin—Anorexia—Doxorubicin—liver cancer	9.07e-05	0.000468	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—PSMD10—liver cancer	9.05e-05	0.00177	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—PSMA4—liver cancer	9.05e-05	0.00177	CbGpPWpGaD
Ofloxacin—Dyspepsia—Epirubicin—liver cancer	9.05e-05	0.000467	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—NR1H4—liver cancer	9.01e-05	0.00176	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—NR1H4—liver cancer	8.97e-05	0.00176	CbGpPWpGaD
Ofloxacin—Decreased appetite—Epirubicin—liver cancer	8.94e-05	0.000462	CcSEcCtD
Ofloxacin—TOP2A—Circadian rythm related genes—PPARG—liver cancer	8.91e-05	0.00174	CbGpPWpGaD
Ofloxacin—Hypotension—Doxorubicin—liver cancer	8.89e-05	0.000459	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Epirubicin—liver cancer	8.88e-05	0.000458	CcSEcCtD
Ofloxacin—Fatigue—Epirubicin—liver cancer	8.86e-05	0.000458	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—GSTA3—liver cancer	8.82e-05	0.00173	CbGpPWpGaD
Ofloxacin—Constipation—Epirubicin—liver cancer	8.79e-05	0.000454	CcSEcCtD
Ofloxacin—Pain—Epirubicin—liver cancer	8.79e-05	0.000454	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—NR1H4—liver cancer	8.73e-05	0.00171	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—liver cancer	8.71e-05	0.0017	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTA3—liver cancer	8.7e-05	0.0017	CbGpPWpGaD
Ofloxacin—Musculoskeletal discomfort—Doxorubicin—liver cancer	8.67e-05	0.000448	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—NR1H4—liver cancer	8.62e-05	0.00169	CbGpPWpGaD
Ofloxacin—Insomnia—Doxorubicin—liver cancer	8.6e-05	0.000444	CcSEcCtD
Ofloxacin—Paraesthesia—Doxorubicin—liver cancer	8.54e-05	0.000441	CcSEcCtD
Ofloxacin—Dyspnoea—Doxorubicin—liver cancer	8.48e-05	0.000438	CcSEcCtD
Ofloxacin—Feeling abnormal—Epirubicin—liver cancer	8.47e-05	0.000438	CcSEcCtD
Ofloxacin—Somnolence—Doxorubicin—liver cancer	8.46e-05	0.000437	CcSEcCtD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—liver cancer	8.43e-05	0.00165	CbGpPWpGaD
Ofloxacin—Gastrointestinal pain—Epirubicin—liver cancer	8.41e-05	0.000434	CcSEcCtD
Ofloxacin—Dyspepsia—Doxorubicin—liver cancer	8.37e-05	0.000433	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—liver cancer	8.36e-05	0.00164	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—ALB—liver cancer	8.31e-05	0.00163	CbGpPWpGaD
Ofloxacin—Decreased appetite—Doxorubicin—liver cancer	8.27e-05	0.000427	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Doxorubicin—liver cancer	8.21e-05	0.000424	CcSEcCtD
Ofloxacin—Fatigue—Doxorubicin—liver cancer	8.2e-05	0.000424	CcSEcCtD
Ofloxacin—Urticaria—Epirubicin—liver cancer	8.17e-05	0.000422	CcSEcCtD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—liver cancer	8.16e-05	0.0016	CbGpPWpGaD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	8.15e-05	0.0016	CbGpPWpGaD
Ofloxacin—Constipation—Doxorubicin—liver cancer	8.13e-05	0.00042	CcSEcCtD
Ofloxacin—Pain—Doxorubicin—liver cancer	8.13e-05	0.00042	CcSEcCtD
Ofloxacin—Abdominal pain—Epirubicin—liver cancer	8.13e-05	0.00042	CcSEcCtD
Ofloxacin—Body temperature increased—Epirubicin—liver cancer	8.13e-05	0.00042	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—CYCS—liver cancer	8.09e-05	0.00158	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—PSMD10—liver cancer	8.09e-05	0.00158	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—PSMA4—liver cancer	8.09e-05	0.00158	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTA4—liver cancer	8.07e-05	0.00158	CbGpPWpGaD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—liver cancer	8.05e-05	0.00157	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—SERPINE1—liver cancer	8.03e-05	0.00157	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTA4—liver cancer	7.96e-05	0.00156	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTA2—liver cancer	7.86e-05	0.00154	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Doxorubicin—liver cancer	7.84e-05	0.000405	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Doxorubicin—liver cancer	7.78e-05	0.000402	CcSEcCtD
Ofloxacin—CYP1A2—Phase II conjugation—GGT1—liver cancer	7.67e-05	0.0015	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTA1—liver cancer	7.58e-05	0.00148	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Epirubicin—liver cancer	7.57e-05	0.000391	CcSEcCtD
Ofloxacin—Urticaria—Doxorubicin—liver cancer	7.56e-05	0.00039	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	7.55e-05	0.00148	CbGpPWpGaD
Ofloxacin—Body temperature increased—Doxorubicin—liver cancer	7.52e-05	0.000388	CcSEcCtD
Ofloxacin—Abdominal pain—Doxorubicin—liver cancer	7.52e-05	0.000388	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—NAT2—liver cancer	7.5e-05	0.00147	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—NAT2—liver cancer	7.4e-05	0.00145	CbGpPWpGaD
Ofloxacin—Asthenia—Epirubicin—liver cancer	7.38e-05	0.000381	CcSEcCtD
Ofloxacin—Pruritus—Epirubicin—liver cancer	7.27e-05	0.000376	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—HMOX1—liver cancer	7.04e-05	0.00138	CbGpPWpGaD
Ofloxacin—Diarrhoea—Epirubicin—liver cancer	7.03e-05	0.000363	CcSEcCtD
Ofloxacin—Hypersensitivity—Doxorubicin—liver cancer	7.01e-05	0.000362	CcSEcCtD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—liver cancer	6.99e-05	0.00137	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	6.93e-05	0.00136	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	6.92e-05	0.00135	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—UGDH—liver cancer	6.91e-05	0.00135	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase II conjugation—GSTP1—liver cancer	6.89e-05	0.00135	CbGpPWpGaD
Ofloxacin—Asthenia—Doxorubicin—liver cancer	6.82e-05	0.000353	CcSEcCtD
Ofloxacin—Dizziness—Epirubicin—liver cancer	6.8e-05	0.000351	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	6.78e-05	0.00133	CbGpPWpGaD
Ofloxacin—Pruritus—Doxorubicin—liver cancer	6.73e-05	0.000348	CcSEcCtD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	6.61e-05	0.00129	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	6.6e-05	0.00129	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	6.59e-05	0.00129	CbGpPWpGaD
Ofloxacin—Vomiting—Epirubicin—liver cancer	6.54e-05	0.000338	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	6.54e-05	0.00128	CbGpPWpGaD
Ofloxacin—Diarrhoea—Doxorubicin—liver cancer	6.51e-05	0.000336	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—EPT1—liver cancer	6.5e-05	0.00127	CbGpPWpGaD
Ofloxacin—Rash—Epirubicin—liver cancer	6.48e-05	0.000335	CcSEcCtD
Ofloxacin—Dermatitis—Epirubicin—liver cancer	6.48e-05	0.000335	CcSEcCtD
Ofloxacin—Headache—Epirubicin—liver cancer	6.44e-05	0.000333	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	6.38e-05	0.00125	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase II conjugation—GSTM1—liver cancer	6.33e-05	0.00124	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—JUN—liver cancer	6.32e-05	0.00124	CbGpPWpGaD
Ofloxacin—Dizziness—Doxorubicin—liver cancer	6.29e-05	0.000325	CcSEcCtD
Ofloxacin—CYP1A2—Metapathway biotransformation—GPX3—liver cancer	6.29e-05	0.00123	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—liver cancer	6.25e-05	0.00122	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	6.23e-05	0.00122	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	6.2e-05	0.00121	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TAT—liver cancer	6.16e-05	0.00121	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—H2AFX—liver cancer	6.11e-05	0.0012	CbGpPWpGaD
Ofloxacin—Nausea—Epirubicin—liver cancer	6.11e-05	0.000315	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—CYCS—liver cancer	6.08e-05	0.00119	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	6.06e-05	0.00119	CbGpPWpGaD
Ofloxacin—Vomiting—Doxorubicin—liver cancer	6.05e-05	0.000312	CcSEcCtD
Ofloxacin—Rash—Doxorubicin—liver cancer	6e-05	0.00031	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—HPGDS—liver cancer	6e-05	0.00117	CbGpPWpGaD
Ofloxacin—Dermatitis—Doxorubicin—liver cancer	5.99e-05	0.00031	CcSEcCtD
Ofloxacin—TOP2A—Circadian rythm related genes—MAPK8—liver cancer	5.98e-05	0.00117	CbGpPWpGaD
Ofloxacin—Headache—Doxorubicin—liver cancer	5.96e-05	0.000308	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	5.75e-05	0.00113	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—PCNA—liver cancer	5.72e-05	0.00112	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—PPARA—liver cancer	5.68e-05	0.00111	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	5.68e-05	0.00111	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	5.68e-05	0.00111	CbGpPWpGaD
Ofloxacin—Nausea—Doxorubicin—liver cancer	5.65e-05	0.000292	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	5.56e-05	0.00109	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	5.54e-05	0.00108	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—H2AFX—liver cancer	5.47e-05	0.00107	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	5.41e-05	0.00106	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	5.29e-05	0.00104	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—liver cancer	5.29e-05	0.00103	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	5.28e-05	0.00103	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	5.24e-05	0.00103	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—PCNA—liver cancer	5.12e-05	0.001	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—LTF—liver cancer	5e-05	0.000979	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TERT—liver cancer	4.94e-05	0.000967	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	4.93e-05	0.000965	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	4.89e-05	0.000957	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP2E1—liver cancer	4.89e-05	0.000956	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	4.82e-05	0.000943	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	4.72e-05	0.000924	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	4.72e-05	0.000923	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	4.59e-05	0.000899	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—TGFB1—liver cancer	4.59e-05	0.000897	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.54e-05	0.000888	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	4.49e-05	0.000879	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GGT1—liver cancer	4.49e-05	0.000878	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—CYCS—liver cancer	4.45e-05	0.00087	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—CYCS—liver cancer	4.4e-05	0.00086	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	4.35e-05	0.000851	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	4.35e-05	0.000851	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	4.34e-05	0.000849	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—PPARA—liver cancer	4.27e-05	0.000836	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ALB—liver cancer	4.22e-05	0.000827	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CPT1B—liver cancer	4.19e-05	0.00082	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GLUL—liver cancer	4.19e-05	0.00082	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TP53—liver cancer	4.17e-05	0.000817	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	4.05e-05	0.000792	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	4.05e-05	0.000792	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NR1H4—liver cancer	4.04e-05	0.000791	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTP1—liver cancer	4.03e-05	0.000789	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	4.02e-05	0.000786	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	3.99e-05	0.000781	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	3.98e-05	0.000778	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTA3—liver cancer	3.97e-05	0.000777	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—liver cancer	3.87e-05	0.000757	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ALDOB—liver cancer	3.87e-05	0.000757	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.82e-05	0.000748	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—RAF1—liver cancer	3.82e-05	0.000748	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—IL6—liver cancer	3.82e-05	0.000748	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—liver cancer	3.78e-05	0.00074	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTM1—liver cancer	3.7e-05	0.000725	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.67e-05	0.000718	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	3.65e-05	0.000715	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTA4—liver cancer	3.63e-05	0.000711	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	3.57e-05	0.000699	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.55e-05	0.000695	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTA2—liver cancer	3.54e-05	0.000693	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP1A1—liver cancer	3.51e-05	0.000687	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	3.46e-05	0.000678	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	3.44e-05	0.000674	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTA1—liver cancer	3.42e-05	0.000668	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	3.41e-05	0.000668	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN2A—liver cancer	3.38e-05	0.000662	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NAT2—liver cancer	3.38e-05	0.000661	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—liver cancer	3.35e-05	0.000655	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.25e-05	0.000635	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALDOB—liver cancer	3.24e-05	0.000634	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	3.22e-05	0.000631	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—liver cancer	3.2e-05	0.000625	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—liver cancer	3.18e-05	0.000621	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—PPARA—liver cancer	3.12e-05	0.000611	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—liver cancer	3.09e-05	0.000605	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CRABP1—liver cancer	3.09e-05	0.000604	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—PPARA—liver cancer	3.09e-05	0.000604	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ADAM17—liver cancer	3.06e-05	0.000598	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN1B—liver cancer	2.99e-05	0.000586	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PSMD10—liver cancer	2.87e-05	0.000562	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PSMA4—liver cancer	2.87e-05	0.000562	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—liver cancer	2.87e-05	0.000562	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CCND1—liver cancer	2.86e-05	0.000559	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—GOT2—liver cancer	2.79e-05	0.000547	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.78e-05	0.000544	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN1A—liver cancer	2.76e-05	0.000541	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HPGDS—liver cancer	2.7e-05	0.000528	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.68e-05	0.000525	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	2.63e-05	0.000515	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—UGDH—liver cancer	2.63e-05	0.000514	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—liver cancer	2.56e-05	0.000502	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—EPT1—liver cancer	2.47e-05	0.000483	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.44e-05	0.000478	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.41e-05	0.000472	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—GOT1—liver cancer	2.41e-05	0.000472	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PSMD10—liver cancer	2.41e-05	0.000471	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PSMA4—liver cancer	2.41e-05	0.000471	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	2.4e-05	0.000469	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GOT2—liver cancer	2.34e-05	0.000458	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TAT—liver cancer	2.34e-05	0.000458	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ALB—liver cancer	2.32e-05	0.000454	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	2.3e-05	0.000451	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ALB—liver cancer	2.29e-05	0.000449	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MYC—liver cancer	2.29e-05	0.000448	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PRKCE—liver cancer	2.23e-05	0.000436	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP2E1—liver cancer	2.2e-05	0.000431	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	2.17e-05	0.000424	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.13e-05	0.000417	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—RAF1—liver cancer	2.1e-05	0.000411	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—RAF1—liver cancer	2.08e-05	0.000406	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYCS—liver cancer	2.06e-05	0.000403	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GOT1—liver cancer	2.02e-05	0.000395	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GGT1—liver cancer	2.02e-05	0.000395	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—H2AFX—liver cancer	1.94e-05	0.00038	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TP53—liver cancer	1.88e-05	0.000368	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTP1—liver cancer	1.81e-05	0.000355	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HMOX1—liver cancer	1.79e-05	0.00035	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MTHFR—liver cancer	1.76e-05	0.000344	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TERT—liver cancer	1.76e-05	0.000343	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.72e-05	0.000337	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTM1—liver cancer	1.67e-05	0.000326	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CPT1B—liver cancer	1.59e-05	0.000311	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GLUL—liver cancer	1.59e-05	0.000311	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP1A1—liver cancer	1.58e-05	0.000309	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NR1H4—liver cancer	1.53e-05	0.0003	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTA3—liver cancer	1.51e-05	0.000295	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APC—liver cancer	1.48e-05	0.000289	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—MTHFR—liver cancer	1.47e-05	0.000288	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPARA—liver cancer	1.45e-05	0.000283	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—BRAF—liver cancer	1.39e-05	0.000272	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTA4—liver cancer	1.38e-05	0.00027	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.35e-05	0.000264	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTA2—liver cancer	1.34e-05	0.000263	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CD—liver cancer	1.3e-05	0.000254	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.3e-05	0.000254	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTA1—liver cancer	1.3e-05	0.000254	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SERPINE1—liver cancer	1.29e-05	0.000252	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NAT2—liver cancer	1.28e-05	0.000251	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CG—liver cancer	1.24e-05	0.000242	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.23e-05	0.000241	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALDOB—liver cancer	1.23e-05	0.000241	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPARG—liver cancer	1.2e-05	0.000234	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CRABP1—liver cancer	1.17e-05	0.00023	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—RAF1—liver cancer	1.16e-05	0.000227	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CB—liver cancer	1.13e-05	0.000222	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MTOR—liver cancer	1.13e-05	0.000222	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CD—liver cancer	1.09e-05	0.000213	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALB—liver cancer	1.07e-05	0.00021	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CDKN1B—liver cancer	1.06e-05	0.000208	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.06e-05	0.000207	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HPGDS—liver cancer	1.03e-05	0.000201	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.02e-05	0.000199	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CTNNB1—liver cancer	1e-05	0.000197	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CDKN1A—liver cancer	9.81e-06	0.000192	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CB—liver cancer	9.49e-06	0.000186	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9.28e-06	0.000182	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	9.17e-06	0.000179	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PSMA4—liver cancer	9.14e-06	0.000179	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PSMD10—liver cancer	9.14e-06	0.000179	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GOT2—liver cancer	8.89e-06	0.000174	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STAT3—liver cancer	8.76e-06	0.000171	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP2E1—liver cancer	8.36e-06	0.000164	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MYC—liver cancer	8.14e-06	0.000159	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TGFB1—liver cancer	8.12e-06	0.000159	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.09e-06	0.000158	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYCS—liver cancer	7.82e-06	0.000153	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GGT1—liver cancer	7.67e-06	0.00015	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GOT1—liver cancer	7.67e-06	0.00015	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—KRAS—liver cancer	7.52e-06	0.000147	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CA—liver cancer	6.91e-06	0.000135	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTP1—liver cancer	6.89e-06	0.000135	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HMOX1—liver cancer	6.8e-06	0.000133	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HRAS—liver cancer	6.39e-06	0.000125	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTM1—liver cancer	6.33e-06	0.000124	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6—liver cancer	6.12e-06	0.00012	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP1A1—liver cancer	6e-06	0.000118	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CA—liver cancer	5.78e-06	0.000113	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKT1—liver cancer	5.64e-06	0.00011	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—MTHFR—liver cancer	5.6e-06	0.00011	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPARA—liver cancer	5.49e-06	0.000107	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.93e-06	9.65e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AKT1—liver cancer	4.73e-06	9.25e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CG—liver cancer	4.7e-06	9.2e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPARG—liver cancer	4.54e-06	8.88e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CD—liver cancer	4.13e-06	8.09e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALB—liver cancer	4.08e-06	7.99e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CB—liver cancer	3.6e-06	7.05e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CA—liver cancer	2.2e-06	4.3e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKT1—liver cancer	1.79e-06	3.51e-05	CbGpPWpGaD
